OS Therapeutics, developer of bone cancer drugs, files for $10 million initial public offering (pending: OSTX)
2d illustrations and photos OS Therapeutics (OSTX), which is developing therapies to treat bone cancer, has applied to raise $10 ...
2d illustrations and photos OS Therapeutics (OSTX), which is developing therapies to treat bone cancer, has applied to raise $10 ...